| 4. EBP1 | Eukaryotic translation initiation factor 4E-binding protein 1 |
| 5-HT1A | Serotonin 1A receptor |
| AKT | Protein kinase B |
| CBD | Cannabidiol |
| CB1 and CB2 | Cannabinoid receptor 1 and 2 |
| CCL3 | Chemokine (C-C motif) ligand 3 |
| CDK | Cyclin-dependent kinase |
| CSS | Combination sensitivity score |
| DOC | Docetaxel |
| DOX | Doxorubicin |
| EGFR | Epidermal growth factor receptor |
| ER+/− | Oestrogen receptor-positive/negative |
| ETC | Electron transport chain |
| FC | Fold change |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| GPR55 | G protein-coupled receptor 55 |
| Id1 | DNA-binding protein inhibitor ID-1 |
| HER2+ | Human epidermal growth factor receptor 2 positive |
| HER3 | Human epidermal growth factor receptor 3 |
| HGNC | HUGO Gene Nomenclature Committee |
| MCM | Minichromosome maintenance proteins |
| MIP-2 | Macrophage Inflammatory Protein-2 |
| mTOR | Mechanistic target of rapamycin |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| ROS | Reactive oxygen species |
| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| PTX | Paclitaxel |
| SN−38 | 7-Ethyl-10-hydroxycamptothecin |
| TAM | Tumour-associated macrophage |
| TRPVs | Family of transient receptor potential (TRP) ion channel |
| TNBC | Triple-negative breast cancer |
| VIN | Vinorelbine |